Pankaj K Singh Selected Research

Oxidoreductases (Dehydrogenase)

9/2022

3D-QSAR and scaffold hopping based designing of benzo[d]ox-azol-2(3H)-one and 2-oxazolo[4,5-b]pyridin-2(3H)-one derivatives as selective aldehyde dehydrogenase 1A1 inhibitors: Synthesis and biological evaluation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pankaj K Singh Research Topics

Disease

84	Neoplasms (Cancer) 04/2024 - 06/2007
41	Pancreatic Neoplasms (Pancreatic Cancer) 04/2024 - 11/2007
16	Adenocarcinoma 11/2023 - 05/2006
13	Neoplasm Metastasis (Metastasis) 01/2024 - 05/2006
7	Hypoxia (Hypoxemia) 01/2024 - 01/2018
6	Breast Neoplasms (Breast Cancer) 03/2024 - 04/2016
5	Cachexia 01/2022 - 01/2014
5	Inflammation (Inflammations) 01/2022 - 08/2017
5	Carcinogenesis 01/2022 - 10/2008
5	Body Weight (Weight, Body) 10/2020 - 01/2014
4	Hemolysis 12/2022 - 08/2017
4	Radiation Injuries (Radiation Sickness) 01/2015 - 07/2011
3	Infections 08/2023 - 01/2020
3	Wounds and Injuries (Trauma) 08/2023 - 05/2013
3	Melanoma (Melanoma, Malignant) 04/2023 - 01/2021
3	Visceral Leishmaniasis (Kala Azar) 02/2023 - 11/2016
3	Colorectal Neoplasms (Colorectal Cancer) 12/2022 - 09/2017
3	Disease Progression 01/2022 - 10/2017
3	Lung Neoplasms (Lung Cancer) 10/2021 - 10/2019
2	Acidosis 03/2024 - 01/2017
2	Thrombosis (Thrombus) 01/2023 - 07/2011
2	Fibrosis (Cirrhosis) 01/2022 - 11/2020
2	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2018
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2017
2	Triple Negative Breast Neoplasms 11/2021 - 01/2017
2	Carcinoma (Carcinomatosis) 10/2021 - 08/2012
2	Skin Neoplasms (Skin Cancer) 04/2021 - 01/2021
2	Atrophy 10/2020 - 01/2020
2	Traumatic Brain Injuries (Traumatic Brain Injury) 07/2019 - 03/2015
2	Insulin Resistance 01/2019 - 12/2010

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 04/2024 - 05/2006
18	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 01/2011
9	EnzymesIBA 01/2024 - 01/2012
7	Glutamine (L-Glutamine)FDA Link 11/2021 - 01/2014
6	MucinsIBA 04/2024 - 11/2007
6	Gemcitabine FDA Link 09/2019 - 01/2016
5	Lactic Acid (Lactate)FDA LinkGeneric 01/2024 - 01/2011
5	CytokinesIBA 01/2023 - 05/2012
4	pyrimidineIBA 04/2023 - 10/2017
4	NucleotidesIBA 04/2023 - 10/2017
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
4	Messenger RNA (mRNA)IBA 01/2022 - 09/2017
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 04/2014
4	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 01/2012
4	Phosphotransferases (Kinase)IBA 04/2021 - 10/2011
4	Adenosine Triphosphate (ATP)IBA 09/2020 - 11/2012
4	MicellesIBA 12/2017 - 01/2016
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2013 - 10/2010
3	PolyaminesIBA 04/2024 - 03/2024
3	AntigensIBA 09/2023 - 03/2018
3	Anti-Bacterial Agents (Antibiotics)IBA 08/2023 - 10/2010
3	CurcuminIBA 12/2022 - 04/2016
3	Neoplasm Antigens (Tumor Antigens)IBA 12/2021 - 03/2018
3	fascinIBA 10/2021 - 10/2019
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2014
3	Conditioned Culture MediaIBA 10/2020 - 01/2019
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2018
3	Mucin-1 (CA 15-3 Antigen)IBA 01/2020 - 08/2012
3	Glycoproteins (Glycoprotein)IBA 01/2017 - 06/2007
2	Acetates (Acetic Acid Esters)FDA Link 04/2024 - 03/2024
2	brequinarIBA 04/2023 - 01/2023
2	Dihydroorotate DehydrogenaseIBA 04/2023 - 01/2023
2	Immune Checkpoint InhibitorsIBA 04/2023 - 03/2018
2	CholesterolIBA 01/2023 - 01/2022
2	SolutionsIBA 12/2022 - 01/2018
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2022 - 01/2016
2	GoldIBA 12/2022 - 11/2021
2	ErbB Receptors (EGF Receptor)IBA 12/2022 - 01/2020
2	Prostaglandin D2IBA 01/2022 - 11/2020
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022 - 05/2012
2	Mitogen-Activated Protein KinasesIBA 01/2022 - 04/2008
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2018
2	AntioxidantsIBA 01/2022 - 01/2015
2	Taxoids (Taxanes)IBA 12/2021 - 01/2017
2	tyrosine receptor (receptor, tyrosine)IBA 04/2021 - 01/2021
2	fisetinIBA 04/2021 - 01/2021
2	3-hydroxyflavoneIBA 04/2021 - 01/2021
2	CyclinsIBA 04/2021 - 01/2021
2	MTOR InhibitorsIBA 04/2021 - 01/2021
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020 - 04/2008
2	Oncogene Proteins (Oncogene Protein)IBA 01/2020 - 04/2008
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 05/2012
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 04/2019 - 01/2019
2	O-GlcNAc transferaseIBA 04/2019 - 01/2019
2	ChitosanIBA 01/2018 - 12/2017
2	Oxygen (Dioxygen)IBA 01/2018 - 07/2011
2	Amphotericin B (Amphotericin)FDA LinkGeneric 12/2017 - 11/2016
2	Fatty Acid Synthases (Fatty Acid Synthase)IBA 10/2017 - 01/2017
2	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2017 - 11/2012
2	Ethylene Glycol (Monoethylene Glycol)IBA 04/2016 - 01/2016
2	monomethoxypolyethylene glycol (MPEG)IBA 04/2016 - 01/2016
2	MicroRNAs (MicroRNA)IBA 04/2012 - 01/2011
1	folfirinoxIBA 04/2024
1	Pentamidine (NebuPent)FDA LinkGeneric 04/2024

Therapy/Procedure

26	Therapeutics 04/2023 - 01/2014
15	Drug Therapy (Chemotherapy) 01/2024 - 10/2008
11	Radiotherapy 12/2022 - 10/2010
3	Immunotherapy 01/2022 - 12/2021
2	Oral Administration 11/2021 - 04/2019
2	Ketogenic Diet 01/2019 - 01/2014